- Enlivex shares hit an all-time low of $0.42, down 94% over five years on Nasdaq.
- Enlivex pivoted to a RAIN token treasury in November 2025 and raised over $200M.
- ZachXBT linked RAIN wallet addresses to accounts tied to Moshe Hogeg in May.
Every retail investor who has ever bought shares of Enlivex on the Nasdaq has now lost money. The stock hit an all-time low of $0.42, falling 94% over five years and 30% decline this year alone.
From Biotech To Crypto Treasury
Enlivex spent years developing clinical therapeutics before abruptly reinventing itself in November 2025 as what it called the world’s first prediction markets digital asset treasury strategy. The company raised over $200 million through a private placement at $1 per share, funded in dollars and USDT, and began accumulating RAIN, a governance token on an Arbitrum-based protocol that it compared to Uniswap for prediction markets.
To add credibility, the company appointed former Italian Prime Minister Matteo Renzi to its board. Investors who bought in at $1 during the November placement have since watched their investment halve.
The ZachXBT Trail
The real damage to sentiment came from on-chain investigator ZachXBT, who flagged RAIN in May this year, warning that retail buyers were providing exit liquidity for insiders. He traced RAIN’s funding to blockchain addresses previously connected to two failed projects, TOMI and Data Ownership Protocol. TOMI was co-founded by Moshe Hogeg, an Israeli entrepreneur facing a $290 million law enforcement investigation. Hogeg has denied fraud allegations through a spokesperson.
ZachXBT concluded that the team behind RAIN is tied to Enlivex and a launchpad called Gems.vip, and that on-chain activity links RAIN wallet addresses to Hogeg-connected accounts.
The Numbers That Do Not Add Up
- Enlivex currently holds approximately 78.8 billion RAIN tokens
- Mark-to-market value of those holdings: $1.2 billion
- Actual market capitalization of Enlivex: $118 million
- RAIN’s share of circulating supply held by Enlivex: Around 12%
The gap between the stated value of the token holdings and the company’s actual market cap points to serious credibility problems. Some of the RAIN is pledged as collateral, limiting how freely it can be sold. A sudden large sale of a position representing 12% of the circulating supply would almost certainly fetch far less than the mark-to-market figure suggests.
Despite RAIN independently rallying substantially since last year, Enlivex shares keep falling. The token’s paper value is not translating into shareholder value, which tells its own story.
Related: ZachXBT Sets Strict Rules for Accepting Crypto Theft Investigations
Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.
